Stocks Explorer
Stocks
Sectors
Search
INNATE PHARMA SP.ADR/1(IDDA) News
Profile
Chart
News
Analysis
IDDA price today
by TradingView
Date
Title
Feb 17
Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome
Jan 10
Innate Pharma Announces Transformative Strategy to Accelerate Growth
‹ Prev
Page
of 1
Next ›